Microcapsules Reducing OIT Leaching via Composite Melamine-Formaldehyde Shells

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing microencapsulated biocides, particularly those containing 2-n-octyl-4-isothiazolin-3-one (OIT), suffer from significant leaching issues, which affect their effectiveness and durability in technical materials.

Innovation Solution

The development of microcapsules using a melamine-formaldehyde polymer as the capsule material, incorporating OIT and/or 3-iodo-2-propynyl-butyl-carbamate (IPBC) with specific weight ratios, which reduces the leaching behavior of OIT and maintains biocidal efficacy by slow release.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If OIT is enclosed in microparticles made of resin, then biocidal protection is provided, but leaching behavior of OIT is significant

Engineering Contradiction:
Improvebiocidal protectionVSAvoidleaching behavior of OIT
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The patent uses composite capsule material consisting of melamine-formaldehyde polymer combined with other polymers (acrylonitrile-butadiene-styrene copolymer, polyvinyl chloride, or carboxymethyl cellulose) to create a multi-component shell that reduces OIT leaching while maintaining biocidal protection. This composite structure provides synergistic effects that prevent OIT release more effectively than single polymers.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent optimizes specific parameters including the weight ratio of melamine-formaldehyde polymer to other polymers (1:4 to 4:1), capsule particle size (0.3 to 100 μm, preferably 5 to 80 μm), and OIT content (0.1 to 10% by weight based on capsule weight) to achieve reduced leaching behavior while maintaining effective biocidal activity.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If capsule wall material is reduced to increase active ingredient content, then biocidal effectiveness is improved, but leaching behavior worsens

Engineering Contradiction:
Improvebiocidal effectivenessVSAvoidleaching behavior
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The patent maintains optimal leaching behavior even with reduced capsule wall material by precisely controlling the composition ratio within the composite material and the OIT content percentage, allowing higher active ingredient loading without proportionally increasing leaching.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The multi-polymer composite structure provides enhanced barrier properties that allow thinner wall sections while maintaining leaching resistance, enabling higher OIT content to be encapsulated effectively.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microcapsules exhibit improved leaching behavior and prolonged action, allowing for effective protection of technical materials with reduced active ingredient usage, while maintaining high biocidal effectiveness against a broad spectrum of fungi.

Implementation Method 1

The term melamine-formaldehyde polymers preferably refers to resins in which melamine has been polycondensed with formaldehyde under suitable conditions

Methodology Applied
Scientific EffectPolycondensation:

Implementation Method 2

the leaching behavior of OIT from the microparticles can be significantly reduced... the active ingredient remains in the material so that it can be used in correspondingly low concentrations. In practical use, the biocide is released only slowly.

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentEP3669654B1Microcapsules comprising oit in combination with propiconazol and/or ipbc
Publication Date: 2021.10.27 LANXESS DEUTSCHLAND GMBH

AI summary

Microcapsules containing a) at least one melamine-formaldehyde polymer as capsule material and b) at least b1) OIT and b2) propiconazole and/or 3-iodo-2-propynyl butylcarbamate (IPBC) as biocide, characterized in that the weight ratio of OIT to the sum of propiconazole and/or IPBC is 5 : 1 to 1 : 5, preferably 1 : 1 to 1 : 5, in particular 1 : 1.5 to 1 : 3.